Medicus, Vol. 30 No. 2 Astma i KOPB, 2021.
Pregledni rad
Do we Recognize a Patient with COPD and Asthma on Time?
Sanda Škrinjarić-Cincar
Eugenija Basioli Kasap
Sažetak
SUMMARYThe World Health Organization points out that one of the essential goals is to reduce morbidity, disability and premature death from chronic respiratory diseases, especially asthma and COPD (Chronic Obstructive Pulmonary Disease). COPD and asthma are chronic lung diseases that differ in many ways, but what they have in common is that the number of patients worldwide is constantly increasing, and that they often remain unrecognized, which adversely affects the final outcome of the disease. Both diseases have a significant share in morbidity and mortality among chronic non-communicable diseases in the world, and each of them in their own way pose a major public health problem. COPD is the third most common cause of death in the world and accounts for as much as 6% of all deaths worldwide. Asthma is the most common chronic disease in children, and because of its characteristics when it occurs in old age, it often goes unrecognized or is misdiagnosed. Non-recognition of the disease, late diagnosis, and non-comprehensive treatment measures in patients with COPD, directly affect morbidity and mortality from this disease. Early interventions applied in the initial stages of COPD can improve the long-term prognosis, prevent loss of lung function, preserve quality of life, and ultimately lead to life-saving and significant savings in treatment. The application of recommendations in the treatment of asthma requires a clear understanding of the concept of control and severity of the disease, as well as response to treatment and awareness of the fact that untreated asthma in addition to causing symptoms and impaired lung function has a high risk of future adverse events.
Ključne riječi
COPD; asthma; prognosis; early diagnosis
Hrčak ID:
264141
URI
Datum izdavanja:
18.10.2021.
Posjeta: 1.255 *